Substance use (SU) stigma is one factor contributing to unmet need for SU treatment. Additionally, theory suggests that women and single parents who use substances experience enhanced stigma because they do not adhere to normative social expectations. This study examines differences in perceived stigma by gender and parenthood among those with unmet need for SU treatment using the 2003-2010 National Survey of Drug Use and Health (N = 1,474). Results indicate that women are more likely to report stigma as a barrier to treatment compared with men, though the interaction between gender and parenthood is not significant. We find that married parents report the highest level of stigma. We situate our findings in past health-related stigma research. We suggest that these results shed a light on stigma, particularly as it relates to family status, as a contributing factor to differences regarding SU treatment utilization. Finally, we raise a provocative question concerning social status and anticipated stigma.
differences in social stigma as a barrier to SU treatment and to focus on the role of the family, both parental and marital status, as contributing to or alleviating perceived stigma as a barrier to SU treatment. Goffman's (1963) seminal work described stigma as "an attribute that is deeply discrediting," which reduces its bearer "from a whole and usual person to a tainted, discounted one" (Goffman 1963, p. 3) . Although stigma can refer to a variety of attributes, health-related stigma has emerged as a significant player in health behavior and outcomes research. Health-related stigma is defined as status loss and discrimination informed by negative attitudes and stereotypes based on health-related conditions (Link & Phelan, 2001) . Two types of stigmas that individuals with a need for SU treatment may face include enacted stigma and perceived (or felt) stigma. Enacted stigma refers to overt rejection and discrimination and may include denial of housing, medical services, social isolation, and verbal and physical assaults (White, Evans, & Lamb, 2009 ). Perceived stigma is a multidimensional concept that encompasses feelings of shame or embarrassment about having a stigmatized health condition as well as anticipation, and fear of, encountering enacted stigma (Carricaburu & Pierret, 1995; Scambler, 2009) . Goffman (1963) also differentiated between discredited and discreditable stigmas. Discredited stigma results from an obvious attribute that can readily be observed and thus the associated stigma is unavoidable. However, a discreditable stigma is a hidden attribute that is not readily apparent. Individuals possessing discreditable attributes often fear disclosure and may seriously alter their behaviors to avoid being identified or to "pass" for nonstigmatized. Similarly, Link (1987) and Link, Cullen, Struening, Shrout, & Dohrenwend (1989) noted in their "modified labeling theory" that secrecy, treatment avoidance, and treatment delay are defensive mechanisms employed as a result of perceived stigma; individuals with stigmatized conditions, including SU, may forgo treatment to avoid the diagnostic label that solidifies them as a member of a stigmatized group.
Background

Health-Related Stigma
The reasons behind SU stigma range from reactions to the negative consequences of drug use to attributions of danger and blame (Lloyd, 2013) . Jones et al. (1984) argued that not all stigmatizing conditions are treated equally and theorized six dimension of stigma that affect the extent to which a condition may be stigmatized. The most highly stigmatized conditions are related to the dimensions of etiology (personal responsibility), concealability (the extent to which it can be hidden), and peril (dangerousness) (Jones et al., 1984) . With regard to etiology, the behavioral component of SU makes it especially vulnerable to stigmatization and likely contributes to the wide spread acceptance of SU as rooted in poor moral character (Baumohl, Speiglman, Swartz, & Stahl, 2003) . With regard to concealability, SU is similar to other progressive illnesses, in that as one's SU increases, the physical toll on the body increases and the ability to conceal one's SU decreases. Finally, SU is strongly associated with peril; individuals engaged in various forms of SU are viewed by many as dangerous (Cunningham, Sobell, & Chow, 1993; Martin et al., 2000; Phelan, Link, Stueve, & Pescosolido, 2000) . Previous research indicates that SU disorders are viewed as the most dangerous psychological disorders when compared with other serious mental illnesses (Link, Phelan, Bresnahan, Stueve, & Pescosolido, 1999; Pescosolido, Monahan, Link, Stueve, & Kikuzawa, 1999) . To be fair, the link between SU and danger is not without merit; research suggests that crime and violence are more frequent among individuals with high levels of SU (Moore, Easton, & McMahon, 2011) . This relationship between SU and harm helps rationalize the stigma of SU disorders.
Though the study of SU stigma and health outcomes is still relatively new, numerous studies have identified SU stigma as a significant predictor of low levels of health services utilization, poor mental and physical health outcomes, and high levels of risk behaviors (Cole, Logan, & Walker, 2011; Frischknecht et al., 2011; Kulesza, Larimer, & Rao, 2013; Latkin, DaveyRothwell, Yang, & Crawford, 2012) . The SU treatment research is replete with studies in which individuals list concern about stigma, privacy, and/or being labeled "alcoholic" or "addict" as primary contributors to treatment avoidance and delay (Cohen et al., 2007; Keyes et al., 2010; Rae Olmsted et al., 2011; Semple, Grant, & Patterson, 2005; White et al., 2009) . Researchers have documented that concerns about privacy and stigma often lead individuals to engage in selective disclosure, treatment avoidance, and treatment delay in order to avoid diagnostic labeling (Palamar, 2012; Saunders, Zygowicz, & D'Angelo, 2006; Semple et al., 2005) .
Motherhood and Substance Use Stigma
Research suggests that various types of stigma may intersect with other attributes of the individual, leading to higher levels of stigmatization for certain segments of the population (Logie, James, Tharao, & Loutfy, 2011) . Researchers argue that the single most important factor that distinguishes the SU and treatment experiences of men and women is the experience of increased stigmatizing attitudes toward female substance users (Covington, 2000) . Attitudes toward SU may be one way in which proscribed gender norms and traditional gendered expectations are enforced (Anderson, 2010; Peralta & Jauk, 2011) .Women who do not conform to socially defined standards of feminine behavior are subjected to negative sanctions for their transgressions including views of female users as dirty, masculine, and sexually available (Anderson, 2010; Boyd, 2004; Parks & Scheidt, 2000) .
The greater stigma that women with SU problems experience may be specifically rooted in a woman's socially defined role as mother and wife (Anderson, 2010; Boyd, 2004; Peralta & Jauk, 2011) . Indeed, negative sereotypes of female users contradict women's normative roles as submissive, chaste, and nurturing caregivers (Fagan, 1994) . This caregiving role is an essential aspect of the gendered role traditionally applied to women, especially those with children. Within the gendered perspective, concerns about SU among women stem from the perception that an intoxicated woman is unable to fulfill her primary socially defined role of caregiver. Therefore, women with SU-related problems are particularly vulnerable to stigmatization (Erickson, Butters, McGillicuddy, & Hallgren, 2000; Heidensohn, 2002; Worrall, 2002) , having transgressed against social codes of behavior and having violated traditional expectations of the roles of wife, mother, and family nurturer (Ettorre, 2007; Fagan, 1994) .
Substance using mothers must constantly live in fear that the label of 'unfit mother' will be applied to them (Boyd, 2004; Linnemann, 2009) , thereby possibly increasing stigma as a barrier to SU treatment. The label of unfit mother, once applied, can carry serious consequences for women, including criminal charges and forfeiture of parental rights (Boyd, 2004; Linnemann, 2009 ). This stigma related to SU and motherhood may push her toward "passing" strategies, avoiding treatment in order to elude the negative social label, and social stigma, that comes with an official diagnosis (Brady & Ashley, 2005; Green, 2006) . Research supports this idea of mothers attempting to "pass"; many pregnant women and new mothers report being afraid that their SU will be discovered and they will lose parental rights (Jessup, Humphreys, Brindis, & Lee, 2003) .
These fears associated with the diagnosis of a SU disorder are not unwarranted among pregnant women and new mothers. Women who are parenting or pregnant have been the object of criminal prosecution in numerous states for years (Murphy, 2014) . Most recently, on April 29, 2014, Tennessee became the first state in the country to authorize the incarceration of women who use drugs while pregnant ("Title 39," 2014) . Although these laws were originally passed in an attempt to deter pregnant women from using substances, they are counterproductive to SU treatment utilization. Numerous health associations, including, but not limited to, the American Medical Association (1990; Chervenak & McCullough, 1991) , the American Academy of Pediatrics (1990) , and the American Public Health Association (1990) have released statements pointing to the likelihood that criminal prosecution of substance using pregnant women will result in greater avoidance of SU treatment and prenatal care. Although it is impossible to summarize the dozens of statements published by various associations regarding the criminalization of SU while pregnant, the following quote from the American Society of Addiction Medicine's Policy Statement on Chemically Dependent Women and Pregnancy summarizes the general consensus:
Criminal prosecution of chemically dependent women will have the overall result of deterring such women from seeking both prenatal care and chemical dependency treatment, thereby increasing, rather than preventing harm to children and to society as a whole. (2005) Parenthood, Martial Status, and Substance Use Stigma SU stigma is magnified in the context of parenthood. The peril, or dangerousness, dimension of social stigma may be particularly relevant when considering SU and the presence of children. Though some studies have shown an association between SU and negative effects on children and the family unit (Barnard & McKeganey, 2004; Walsh, MacMillan, & Jamieson, 2003) , parents suffering from substance-related problems are painted with a broad, stereotypical brush. Combining data collected from numerous studies, Klee (1998) reports that health professionals frequently describe parents with SU problems as "selfish and uncaring, irresponsible, distracted, neglectful, intolerant, irritable and aggressive, no(t engaging in) child-centered activity, (and) put(ting) drugs before (their) child" (p. 439). The possibility of facing enacted stigma from health care providers provides a strong incentive to avoid seeking treatment among parents with SU problems.
Furthermore, according to socialization theories, a two-parent household is the ideal environment for child rearing (David, Demo, & Acock, 1996) , thus individuals who do not conform to the traditional, heterosexual, twoparent ideal family structure face various forms of social stigma (Lansford, Ceballo, Abbey, & Stewart, 2001; Lauster & Easterbrook, 2011) . For single parents who engage in various forms of SU, the social stigma of single parenthood may enhance feelings of stigma overall. Although single parents may face multiple barriers to SU treatment (i.e., economic and child care burdens), the intersection of single parenthood stigma and SU stigma may further decrease one's likelihood to seek treatment services.
Hypotheses
A thorough search of the literature has uncovered that no quantitative investigation has been published to validate these theoretical propositions regarding gender, parenthood status, marital status, and stigma. Previous research has indicated that SU stigma as a barrier to treatment does exist among women (Greenfield et al., 2007) , but an analysis of stigma as a barrier which compares men and women with respect to has yet to be conducted. Furthermore, an investigation of how family structure may affect SU stigma is also missing from the literature. Understanding the factors that increase perceived stigma as a barrier to SU treatment will facilitate providing adequate treatment and incentivizing substance users to seek treatment. This analysis addresses this gap in research, conducting an empirical analysis to examine gender differences in stigma as a barrier to SU treatment, and examining the potential role that parenthood and marital status may play in this relationship.
Based on theory and past research, we believe that women will be more likely to report social stigma as a barrier to SU treatment. Furthermore, taking into account the traditional expectations of motherhood and family structure, we expect that mothers and single parents will report more stigma-related barriers than father or married parent families.
Hypothesis 1: Women with unmet need for SU treatment will report greater stigma-related barriers than men with unmet need. Hypothesis 2: Parents with unmet need for SU treatment will report greater stigma-related barriers than nonparents with unmet need. Hypothesis 3: Parenthood is significantly more likely to be associated with stigma for women compared with men among those with unmet need for SU treatment. Hypothesis 4: Never-married parents are more likely to report stigma as a barrier to SU treatment than married or formerly married parents with unmet need for SU treatment.
Data and Method
Data for this study were drawn from the public use file of the NSDUH (SAMHSA, 2004 -2011 . The NSDUH is conducted on an annual basis to provide nationally representative data on the incidence and prevalence of drug, alcohol, and tobacco use by persons 12 years and older, within the United States. The NSDUH covers topics such as illicit drug use, alcohol use, substance abuse treatment history, and perceived need for treatment. The survey is conducted using face-to-face interview techniques at the respondent's home. To ensure confidentiality, questions concerning SU and mental health are completed using computer-assisted interview technology. A more detailed description of the sampling methodology for the NSDUH survey is publically available (Morton, Martin, Chromy, Hirsch, & Ridenhour, 2011) .
The NSDUH only inquires about SU stigma in the context of barriers to treatment and as such, only participants with unmet need are asked about stigma concerns. For the purpose of this research, the target population included individuals older than the age of 18 years with unmet need for SU treatment. Unmet need is defined as a personal recognition for treatment by the individual and a failure to seek out such treatment. Listwise deletion was used if the respondent is missing on any of the research variables, resulting in dropping approximately 6% of the sample. Listwise deletion is seen as an appropriate method to handle missingness, when there is less than 10% missing in the sample (Allison, 2001 ). The final sample size is 1,474 cases.
Criterion Variable
The criterion variable, perceived stigma as a barrier to SU treatment, was constructed using responses to the following question: "Which of these statements explain why you did not seek the treatment you needed for your use of [substance]?" Respondents were given 14 options from which they could choose one or more reasons for not receiving treatment. Consistent with previous research, which has utilized the NSDUH data set to examine treatment-seeking behaviors and stigma (Alang, 2014; Brown et al., 2010; Mojtabai, Olfson, & Mechanic, 2002; SAMHSA, 2009; Townsend, Gearing, & Polyanskaya, 2012) , a combination of the following three options were used to create the criterion variable for this study: (a) You did not want others to find out that you needed treatment (yes/no), (b) You were concerned that getting treatment or counseling might cause your neighbors or community to have a negative opinion of you (yes/no), (c) You were concerned that getting treatment or counseling might have a negative effect on your job (yes/no). An affirmative response to one or more of these items is coded as a report of stigma as a barrier to treatment (stigma = 1, no stigma = 0). Additionally, sensitivity analyses took into account that individuals were allowed to respond affirmatively to multiple barriers by examining stigma as a count variable and also examining differences among individuals who reported only stigma-related barriers to those who reported stigma and other related barriers. Results indicated no significant differences (not shown).
Predictor Variables. The predictor variables of interest include sex, marital status, and parenthood status. Sex and marital statuses are based on self-report; marital status is coded as never married, married (reference), and formerly married (divorced, widowed, and separated). Parenthood status is defined as having one or more of the respondent's own children, less than 18 years of age, living in the household at the time of the survey administration. Controls include race (non-Hispanic White and non-White or Hispanic, referred to herein out as White and non-White), education (less than high school, high school education, and at least some college), age, which is measured using four age groups (18 to 20 years old, 21 to 25 years old, 26 to 34 years old, and 35 years old or older), and income. Total family income is measured using seven categories; less than $10,000, $10,000 to $19,999, $20,000 to $29,999, $30,000 to $39,999, $40,000 to $49,999, $50,000 to $74,999, and $75,000 or more and is treated as continuous.
The hypotheses identified above are examined using nested logistic regression and are evaluated with STATA software (ver. 11; StataCorp., 2009 ). This statistical method was chosen to account for the binary nature of the criterion variable. Model 1 tests Hypotheses 1 and 2 by regressing our focal predictor variables (sex, parenthood status, and marital status) on stigma (stigma = 1). Model 2 includes the sociodemographic control variables to determine if a relationship exists between the predictor and criterion variable after controlling for these factors. Last, Hypotheses 3 and 4, whether the association between parenthood and stigma varies by marital status or sex, are evaluated by including interactions in Model 3. Table 1 contains descriptive statistics for the analytic sample and also broken down by sex and parenthood status. Significance tests were conducted using chi-square tests and t tests and indicate significant differences between men and women. Consistent with Hypothesis 1, among those with unmet need for SU treatment, we find that women are more likely than men to report stigma as a barrier to treatment (26.3% of women and 20.2% of men, p < .01). Additionally, we find that women are more likely to be parents compared with men (44.9% of women are parents compared with 36.9% of men p < .01) and are more likely to be formerly married compared with men (18.6% of women compared with 13.2% of men, p < .05). However, there are no significant differences in stigma by parenthood status (p = .34, not shown), between mothers and nonmothers (p = .42), or between fathers and nonfathers (p = .92, not shown). Additionally, there are no significant differences in stigma by marital status (p = .11, not shown). Thus, our descriptive statistics find support for Hypothesis 1, women are more likely to report stigma as a barrier to treatment compared with men, but fail to find support for Hypotheses 2, 3, and 4. Examining the control variables, we find that women are more educated compared with men (41.3% of women had at least some college compared with 31.2% of men, p < .01), but have lower incomes (3.5 for women compared with 3.8 for men p < .01). Examining demographic 
Results
Multivariate Analyses
The general patterns found above are examined in multivariate logistic regression. Table 2 presents odds ratios (ORs) and 95% confidence intervals (CIs) predicting perceived stigma as a barrier to SU treatment. Model 1 contains the main predictor variables, sex, parenthood status, and marital status and confirms the findings from the descriptive results. Sex is significantly associated with reporting greater stigma as a reason for unmet need; women have 44% greater odds of reporting stigma as a barrier to SU treatment compared with men (p < .01). Additionally, we now find that formerly married individuals have lower odds of reporting stigma than married individuals (OR = 0.61, p < .05). However, there are no differences by parenthood status. Model 2 adds our socioeconomic and demographic control variables. Controlling for these variables partially accounts for the significant sex differences in perceived stigma, OR for women is reduced from 1.44 to 1.32 (p < .05).
In Model 2, we also find significant relationships between the sociodemographic control variables and perceived stigma as a barrier to SU treatment. Higher total family income is associated with a greater likelihood to report stigma as a barrier to SU treatment (OR = 1.15, p < .000). Compared with those with less than a high school degree, those with at least some college have nearly two and a half times to the odds of reporting stigma as a reason for unmet need (OR = 2.47, p < .001). Examining the demographic characteristics, we find that Whites have 42% (p < .05) higher odds of reporting stigma as barrier to treatment compared with non-Whites. Sex differences on the descriptive variables and the mediation of the sex difference once controls are added to the model suggest that the greater likelihood for women to perceive stigma as a barrier to SU treatment is partially due to their higher educational attainment and greater likelihood of being White. Additionally, we found that being formerly married is no longer significant once sociodemographic controls are included. This appears to be due to the greater likelihood to have lower socioeconomic status (SES) among formerly married individuals compared with married individuals. Note. SU = substance use; OR = odds ratio; CI = confidence interval. +p < .1. *p < .05. **p < .01. ***p < .001.
Model 3 tests Hypothesis 3 that parenthood is significantly more likely to be associated with stigma for women compared with men and Hypothesis 4 that never married parents have greater stigma then married parents. This is done by including interaction terms between sex and parenthood status and between parenthood and marital status. The interaction between sex and parenthood is not significant and fails to support our third hypothesis. Parenthood does not significantly interact with gender, however in additional analyses (see Appendix, Table A2 ) we examine parenthood and gender additively by creating four separate groups; mothers, nonmothers, fathers, and nonfathers. We find that compared with mothers, nonmothers and nonfathers both are less likely to experience stigma as a barrier to treatment (OR = 0.64, p < .05 and .51, p < .001, respectively). Additionally, fathers are less likely to experience stigma as a barrier to treatment than mothers, but this fails to reach significance (OR = 0.71, p = .09). Thus, we fail to find support for Hypothesis 3.
Model 3 also indicates that the interaction between parent and never married is significant and indicates that, contrary to Hypothesis 4, never married parents experience less stigma than married parents (OR = 0.42, p < .05). This interaction is depicted in Figure 1 , which displays the predicted log odds of experiencing stigma as a barrier to unmet need among our different groups of parent and marital status. Indeed, married parents are the most likely to report stigma as a barrier to SU treatment than any of the other parent and marital status groups. Care should be taken in Figure 1 . Predicted log odds of stigmas a barrier among those with unmet need, by parent and marital status. NSDUH, 2003 NSDUH, -2010 interpreting the association of stigma for the formerly married group by parenthood status given their small sample size (only 85 formerly married respondents are parents) and large CIs.
Discussion
Social stigma remains a strong barrier to SU treatment utilization, despite the medicalization of the condition more than 60 years ago (American Psychiatric Association, 1952) . The goal of this analysis was to provide empirical support for sex differences in the role of perceived stigma as a barrier to SU treatment and examine the extent that this association was moderated by parenthood. This article tested the hypothesis that substance using women would report more stigma-related barriers to treatment than men. The stricter norms concerning SU among women was suspected to increase the strength of the perceived stigma experienced by women with unmet need for SU treatment and manifest itself in perceived stigma acting as a stronger barrier to SU treatment for women than for men.
Indeed, we find that women were more likely to report perceived stigma as a barrier to SU treatment compared with men. Women with unmet need had 44% greater log odds of reporting perceived stigma as a reason that they did not seek SU treatment in the last year. However, these sex differences were partially accounted for by our controls, especially race and education. Compared with men, women with unmet need were more likely to be White and have a higher education, both of which were positively associated with perceived stigma as a barrier to SU treatment. We also find support for our second hypothesis, which examined whether parenthood was associated with a greater likelihood of indicating that stigma was a barrier to receiving SU treatment, after controls for sociodemographic characteristics are included in the model; parents have 49% greater odds of reporting stigma compared with nonparents.
Our third model illustrates that the association between parenthood and stigma is not significantly different for men compared with women. Although our third hypothesis was not supported in the interaction model, further analysis (see Appendix, Table 2A ) supported this association additively. The combined effects of greater stigma among women and parents results in mothers experiencing the most stigma compared with father, nonmothers, or nonfathers. However, the difference between mothers and fathers fails to reach significance, both fathers and mothers experience greater stigma than their nonparent counterparts. This highlights the impact of how gender roles and family status affect individual's ability to seek SU treatment when they are in need of it. Additionally, it underscores how parenthood status should be addressed in attempting to decrease stigma and increase utilization of treatment. Addressing this seems especially pertinent given the negative health outcomes found for children who have substance using parents (Osborne & Berger, 2009 ). Though female focused interventions specifically focus on family and are usually the targets for interventions when parent status is considered, this analysis also demonstrates that fathers experience greater stigma as well.
Concerning our fourth hypothesis, this analysis revealed surprising results; individuals who are married parents were more likely to report stigma as a barrier to SU treatment than never married parents. Although these results were unexpected, they are consistent with findings in Model 2, individuals with nonmarginalized statuses are more likely to report stigma as a barrier to SU treatment. In Model 2, we see that individuals who identify as White, have higher levels of education, and report higher incomes are more likely to report stigma as a barrier to SU treatment as well. One way to interpret these findings is that individuals with higher social status may be more concerned about possible status loss from seeking treatment compared with those with lower social status. Consequently, treatment avoidance based on stigmarelated barriers may vary based on the amount of social status a person feels she or he has to lose (Ojeda & Bergstresser, 2008) . Alternatively, it could be that individuals who already face various other forms discriminations and stigmas (single parents, non-Whites, those with lower SES) may be less sensitive to SU stigma compared with those who do not face stigma based on these group memberships.
Our findings concerning marginalized and nonmarginalized populations present a new and provocative question for stigma researchers: Does higher social status increase anticipated stigma? Although nonmarginalized populations may anticipate more social stigma, much research indicates that more marginalized populations experience greater enacted stigma (Hartwell, 2004; Logie et al., 2011; Loutfy et al., 2012; Storholm et al., 2013) . Our finding can be significantly informed by fundamental cause theory. Although much of the focus in fundamental cause theory research has been on SES, in a recent volume of the American Journal of Public Health, Hatzenbuehler et al. (2013) argued that stigma should also be considered as a "fundamental cause of population health inequalities." In their seminal work on the theory, Link and Phelan (1995) argue that flexible resources play a central role in the relationship between SES and health outcomes. Flexible resources, such as money, knowledge, power, prestige, and beneficial social connections, can be deployed to avoid risk or to adopt protective strategies to reduce negative outcomes. Thus, it is reasonable to consider that, access to various social resources may protect nonmarginalized persons from actually experiencing enacted stigma, but leave those without these resources at greater risk for experiencing enacted stigma. Although individuals with more flexible resources may employ these resources to avoid enacted stigma, this same access to resources is threatened by the possibility of enacted stigma; thus, fear of facing enacted stigma and losing social status may act to increase the extent that perceived stigma affects treatment seeking. A comparison of anticipated stigma and enacted stigma among these two groups would facilitate our understanding of the ways in which social status may affect stigma experiences.
Limitations and Conclusions
Though this is the first study to empirically examine sex difference in perceived stigma as a barrier to SU treatment, it is not without its limitations. The first limitation is that treatment was defined as only using formal treatment, which understates the extent that individuals with SU problems seek treatment. Though formal treatment is consistently associated with positive outcomes among this population (Grella et al., 2010; Storbjörk & Ullman, 2012) , formal treatment is only one pathway to the treatment of substancerelated disorders. Popular alternatives to formal treatment include 12-step programs, such as Alcoholics Anonymous, and attempts at self-recovery (natural recovery) (Humphreys et al., 2004; Tucker & Simpson, 2011) . It is possible that stigma and discrimination are strong among recovering substance users who decide to forgo formal treatment options in favor of other treatment options; however, the present study was not able to tease out those who relied on self-help organizations rather than formal substance treatment and thus was unable to examine the extent to which the stigma-related barriers informed choices of treatment modalities.
Second, this research is only cross-sectional and implies associations only. Longitudinal data would allow researchers to examine how changes in stigma are associated with treatment seeking behaviors would be ideal. Future longitudinal research could expand our understanding by including individuals who ultimately did seek treatment, formal and informal, which would allow for a better assessment of the extent to which stigma affects decisions on the type of treatment one chooses and its effects on treatment delay. Unfortunately, a representative data set which would allow for longitudinal analysis of stigma and treatment-seeking behavior is not currently available. The NSDUH data set, stigma questions are only asked among those with unmet need, thus this data can only be used to examine stigma as a barrier to treatment among those with unmet need. Furthermore, our analyses do not take into account various other barriers that parents or women may face. Treatment seeking requires not only the desire to receive treatment and the access to such services but also on the availability of a wide range of resources. For parents, the lack of availability of facilities that provide child care services may be an important barrier to SU treatment. Most SU treatment programs do not allow for parents to bring their children with them, do not provide child care services, nor do they help arrange for temporary guardianship while the parent is in treatment. Our analysis was not able to disentangle the complex relationship between perceived stigma and these structural barriers that many parents face. Future stigma research would benefit from a comparison of traditional treatment facilities and those that cater specifically to the needs of parents, especially mothers.
Similarly, our definition of stigma directly relies on barriers to seeking treatment and does not address the complex relationship of stigma. A continuous measure could provide a more nuanced understanding of the phenomenon in question. In many areas of stigma research, scales which provide continuous measures are avalable includingthe Berger Scale for HIV stigma (Berger, Ferrans, & Lashley, 2001 ), the Perceived Devaluation Discrimination Scale for Mental Illness Stigma (Link, Mirotznik, & Cullen, 1991) . Although researchers are currently developing continuous scales to measure substance abuse stigma among current substance users (Palamar, Kiang, & Halkitis, 2011) , data related to this topic are not currently available in nationally representative data. However, because participants were allowed to select more than one reason as to why they did not seek treatment, we used a negative binomial, with the number of stigma-related barriers as a count variable, to examine our hypothesis as well (n = 1,139 for 0, n = 220 for 1, n = 95 for 2, and n = 20 for 3 stigma barriers). Because the results of the negative binomial regression model were not different from the original outcome (not shown), and because prior research provides a basis for the dichotomous use of the NSDUH stigma variables (Alang, 2014; Brown et al., 2010; Mojtabai et al., 2002; SAMHSA, 2009; Townsend et al., 2012) , we have chosen to only include the dichotomous stigma variable for publication.
Although effective treatment for substance-related disorders are widely available, adults with need for these services underutilize them (Cohen et al., 2007) . Understanding barriers to treatment utilization is necessary in developing accessible treatment opportunities. Any examination of treatment utilization, avoidance, or delay must begin with an acknowledgment that stigma, SU, and SU treatment are complex social phenomenon. Decisions to seek treatment are influenced by a variety of factors including social stigma, economic status, clinical settings, familial relationships, and personal dispositions. The extent to which these factors individually inform the decision to seek, avoid, or delay treatment is not easily untangled. This research has added to the understanding of treatment-seeking behaviors; illustrating that parenthood status and marital status are important to understanding differences in stigma as a barrier to SU treatment. Note. NSDUH = National Survey of Drug Use and Health; SU = substance use; OR = odds ratio; CI = confidence interval. +p < .1. *p < .05. **p < .01. ***p < .001.
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